MatrixDB is a freely available database focused on interactions established by extracellular matrix proteins, proteoglycans and polysaccharides
| Source | Last Updated |
|---|---|
| MatrixDB | May 10, 2022 |
| ID | Label | Method | Experimental | Species | ChEBI | Complex Portal | GlyTouCan ID | KEGG ID | LIPID MAPS | UniProt IDs ▲ |
|---|---|---|---|---|---|---|---|---|---|---|
| MULT_5_VAR3_mouse |
|
|
Mus musculus | CPX-2964 | ||||||
| MULT_46_chick |
|
|
Gallus gallus | CPX-3173 | ||||||
| PFRAG_95_human |
|
|
Homo sapiens | |||||||
| PFRAG_92_human |
|
|
Homo sapiens | |||||||
| PFRAG_29_human | Factor VIIIa heavy chain, 200 kDa isoform |
|
|
Homo sapiens | ||||||
| PFRAG_30_human |
|
|
Homo sapiens | |||||||
| PFRAG_31_human |
|
|
Homo sapiens | |||||||
| PFRAG_32_human |
|
|
Homo sapiens | |||||||
| PFRAG_33_human |
|
|
Homo sapiens | |||||||
| PFRAG_9_human | Angiostatin |
|
|
Homo sapiens | ||||||
| PFRAG_34_bovine |
|
|
Bos taurus | |||||||
| PFRAG_34_human |
|
|
Homo sapiens | |||||||
| PFRAG_35_human | Angiotensin-3 |
|
|
Homo sapiens | ||||||
| PFRAG_18_human | Complement C3 beta chain |
|
|
Homo sapiens | ||||||
| PFRAG_17_human |
|
|
Homo sapiens | |||||||
| PFRAG_36_human | Complement C3d fragment |
|
|
Homo sapiens | ||||||
| PFRAG_18_mouse |
|
|
Mus musculus | |||||||
| PFRAG_17_mouse |
|
|
Mus musculus | |||||||
| PFRAG_37_human |
|
|
Homo sapiens | |||||||
| PFRAG_38_human |
|
|
Homo sapiens | |||||||
| MULT_79_human | PDGF-AB |
|
|
Homo sapiens | CPX-1875 | |||||
| MULT_78_human | PDGF-BB |
|
|
Homo sapiens | CPX-1876 | |||||
| PFRAG_19_human |
|
|
Homo sapiens | |||||||
| PFRAG_39_human |
|
|
Homo sapiens | |||||||
| PFRAG_40_human | Beta-nerve growth factor |
|
|
Homo sapiens |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025